With a market cap of has a large market cap size. Grifols, S.A. (NASDAQ: GRFS) has been on the stock market since its IPO date on the 6/2/2011. Grifols, S.A. is in the Biotechnology industry and Healthcare sector. Average volume for Grifols, S.A., is 1283.33, and so far today it has a volume of 736899. Performance year to date since the 6/2/2011 is 4.62%.
To help you determine whether Grifols, S.A. is undervalued the following values will help you decide. P/E is 38.16 and forward P/E is 14.73. PEG perhaps more useful shows that Grifols, S.A. has a value for PEG of 2.54. P/S ratio is 5.22 and the P/B ratio is 6.31. The P/Cash and P/Free cash flow is *TBA and *TBA respectively.
At the current price Grifols, S.A. is trading at, 16.83 (0.24% today), Grifols, S.A. has a dividend yield of 3.10%, and this is covered by a payout ratio of *TBA. Earnings per share (EPS) is 0.44, and this is looking to grow in the next year to 10.70% after growing 3.00% this past year. EPS growth quarter over quarter is -2.50%, and 5.60% for sales growth quarter over quarter.
The number of shares outstanding is 1370, and the number of shares float is 1100. The senior management bring insider ownership to *TBA, and institutional ownership is at *TBA. The float short is 0.12%, with the short ratio at a value of 1.07. Management has seen a return on assets of *TBA, and also a return on investment of *TBA.
The ability for Grifols, S.A., to deal with debt, means it current ratio is *TBA, and quick ratio is *TBA. Long term debt/equity is *TBA and total debt/equity is *TBA. In terms of margins, Grifols, S.A. has a gross margin of *TBA, with its operating margin at *TBA, and Grifols, S.A. has a profit margin of *TBA.
The 52 week high is -4.77%, with 20.75% being its 52 week low. The 20 day simple moving average is 5.10% and the 200 day simple moving average is 6.45%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.